- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gland Pharma Limited's Board of Directors, at a meeting held on August 5, 2025, approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2025. These results, along with the limited review report, are now available for investor review. Shareholders can access the full details on the company's official website and the websites of BSE Limited and National Stock Exchange of India Limited. This provides key insights into the company's recent financial performance, crucial for stakeholder analysis.